1-[2-(4-吗啉基)乙基]-1H-吲哚 | 72395-48-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 1-[2-(4-吗啉基)乙基]-1H-吲哚
• 英文名称: 1-<2-(4-morpholinyl)ethyl>-1H-indole
• 英文别名: 1-[2-(4-morpholino)ethyl]-3-(1-naphthoyl)indole；4-(2-(1H-indol-1-yl)ethyl)morpholine；4-(2-indol-1-ylethyl)morpholine
• CAS: 72395-48-3
• 化学式: C₁₄H₁₈N₂O
• mdl: MFCD19011430
• 分子量: 230.31
• InChiKey: JKBSHWYEEAPKIN-UHFFFAOYSA-N

物化性质

• 沸点：
  180-185 °C(Press: 7 Torr)
• 密度：
  1.14±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.428
• 拓扑面积：
  17.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-[2-(4-吗啉基)乙基]-1H-吲哚 在 lithium aluminium tetrahydride 、 三氯化铝 、 氯化二乙基铝 作用下， 以 乙醚 、 正己烷 、 二氯甲烷 为溶剂， 反应 50.0h， 生成 (1-(2-morpholin-4-yl-ethyl)indol-3-yl)-naphthalen-1-yl-methane
  参考文献：
  名称：

  3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB1 cannabinoid receptor

  摘要：

  A series of 1-pentyl-1H-indol-3-yl-(1-naphthyl)methanes (9 11) and 2-methyl-1-pentyl-1H-indol-3-yl-(1-naphthyl)methanes (12-14) have been synthesized to investigate the hypothesis that cannabimimetic 3-(1-naphthoyl)indoles interact with the CB I receptor by hydrogen bonding to the carbonyl group. Indoles 9-11 have significant (K-i 17-23 nM) receptor affinity, somewhat less than that of the corresponding naphthoylindoles (5, 15, 16). 2-Methyl-1-indoles 12-14 have little affinity for the CB1 receptor, in contrast to 2-methyl-3-(1-naphthoyl)indoles 17-19, which have affinities comparable to those of 5, 15, 16. A cannabimimetic indene hydrocarbon (26) was synthesized and found to have K-i = 26 +/- 4 nM. Molecular modeling and receptor docking studies of naphthoylindole 16, its 2-methyl congener (19) and indolyl-1-naphthylmethanes 11 and 14, combined with the receptor affinities of these cannabimimetic indoles, strongly suggest that these cannabinoid receptor ligands bind primarily by aromatic stacking interactions in the transmembrane helix 3-4-5-6 region of the CB1 receptor. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(02)00451-0
• 作为产物：
  描述：

  2-吗啉乙醇 在 sodium hydride 、 三乙胺 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 生成 1-[2-(4-吗啉基)乙基]-1H-吲哚
  参考文献：
  名称：

  吲哚-3-基环烷基酮：N1取代的吲哚侧链变异对CB 2大麻受体活性的影响

  摘要：

  已经制备了几种对CB 2大麻素受体具有高亲和力并且对CB 1受体具有选择性的3-酰基环吲哚。各种3-酰基取代基进行了调查，和四甲基环组被发现导致高亲和力CB 2激动剂（5，16）。然后检查在N1-吲哚位置的取代。（A系列aminoalkylindoles的制备和几个取代氨基乙基衍生物是活性23 - 27，5在CB）2受体。N1非芳香族侧链变异体的研究为CB 2受体提供了有效的激动剂（16，35 - 41，44 - 47，49 - 54，和57 - 58）。几个极性侧链（醇类，恶唑烷酮）的良好的耐受性为CB 2受体的活性（41，50），而其他（酰胺，酸）导致较弱的或无活性的化合物（55和56）。N1芳香族侧链还提供几个高亲和力CB 2受体激动剂（61，63，65，和69），但是在体外CB一般不太有效的2个功能测定法均高于非芳香族侧链类似物。

  DOI：

  10.1021/jm901214q

文献信息

• Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis
  作者：Ying Shi、Yan-Hui Duan、Yue-Yang Ji、Zhi-Long Wang、Yan-Ran Wu、Hendra Gunosewoyo、Xiao-Yu Xie、Jian-Zhong Chen、Fan Yang、Jing Li、Jie Tang、Xin Xie、Li-Fang Yu

  DOI：10.1021/acs.jmedchem.7b00724

  日期：2017.8.24

  in potent CB2 antagonists (27 or 28, IC50 = 16–28 nM). Replacement of the amidoalkyls from 3-position to the 2-position of the indole ring dramatically increased the agonist selectivity on the CB2 over CB1 receptor. Particularly, compound 57 displayed a potent agonist activity on the CB2 receptor (EC50 = 114–142 nM) without observable agonist or antagonist activity on the CB1 receptor. Furthermore,

  选择性CB 2激动剂代表了一种有吸引力的治疗策略，可用于治疗各种疾病，而无需CB 1受体介导的精神病副作用。我们对黑市设计师药物SDB-001进行了合理的优化，从而确定了有效的和选择性的CB 2激动剂。3-氨基烷基吲哚处的7-甲氧基或7-甲硫基取代产生有效的CB 2拮抗剂（27或28，IC 50 = 16-28 nM）。从吲哚环的3位到2位取代酰胺基烷基大大提高了CB 2上的激动剂选择性，而不是CB 1上受体。特别是，化合物57对CB 2受体表现出有效的激动剂活性（EC 50 = 114–142 nM），而对CB 1受体没有明显的激动剂或拮抗剂活性。此外，在多发性硬化症的实验性自身免疫性脑脊髓炎（EAE）小鼠模型中，有57个显着减轻了临床症状并保护了小鼠中枢神经系统免受免疫损伤。
• Transfer of activation from indoles to alcohols: A new method for the synthesis of aminoethylindoles
  作者：Michael A. Eissenstat、John D. Weaver

  DOI：10.1016/0040-4039(95)00229-6

  日期：1995.3

  Transfer of a sulfonyl group from an indole nitrogen to a β-amino alkoxide generates an indole anion and an aminoethylsulfonate which react to give aminoethylindoles.

  磺酰基从吲哚氮到β-氨基醇盐的转移产生吲哚阴离子和氨基乙基磺酸盐，它们反应生成氨基乙基吲哚。
• 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES
  申请人：Bursavich Matthew Gregory

  公开号：US20090311217A1

  公开（公告）日：2009-12-17

  The invention relates to 3-substituted-1H-indole compounds of the Formula I: or a pharmaceutically acceptable salt thereof, wherein the constituent variables are as defined herein, compositions comprising the compounds, and methods for making and using the compounds.

  本发明涉及公式I的3-取代-1H-吲哚化合物或其药学上可接受的盐，其中组成变量如本文所定义，包括该化合物的组合物，以及制备和使用该化合物的方法。
• Synthesis, Molecular Docking and Biological Evaluation of <i>N</i> ‐Substituted Indole Derivatives as Potential Anti‐Inflammatory and Antioxidant Agents
  作者：Archana Kumari、Rajesh Kumar Singh

  DOI：10.1002/cbdv.202200290

  日期：2022.9

  Novel N-substituted Indole derivatives with various hetero-cyclic moieties were synthesized via an ethyl linker in order to obtain highly potent anti-inflammatory and antioxidant agents. The structure of the obtained chemical compounds was determined using IR, 1H-NMR, and mass spectroscopy. Molecular docking was used to create selective and efficient COX-2 inhibitors from twelve novel indole derivatives

  通过乙基接头合成了具有各种杂环部分的新型N-取代吲哚衍生物，以获得高效的抗炎和抗氧化剂。使用IR、 1 H-NMR和质谱确定获得的化合物的结构。分子对接用于从十二种新型吲哚衍生物（11a – c、12a – c、13a – c和14a – c）中产生选择性和高效的 COX-2 抑制剂。化合物13b和14b具有较高的相互作用能，可抑制 COX-2 酶。根据作用机制，抗炎活性和抗氧化剂之间存在关系，这也由 COX-2 抑制定义。瑞士 ADME 在线程序用于确定合成化合物的类药物特性。采用两种常用且可靠的方法来确定抗氧化效果。在 DPPH 测定中，化合物11a、11b和14b，而化合物11b、13b和14b在还原力测定中，与标准抗坏血酸相比，是最有效的。为了评估急性和慢性水平的抗炎作用，在低剂量和高剂量下使用角叉菜胶诱导的爪水肿法和福尔马林诱导的炎症法。从收集的结果来看，化合物13b和14b对急
• Aminoalkylindoles: Structure-Activity Relationships of Novel Cannabinoid Mimetics
  作者：Michael A. Eissenstat、Malcolm R. Bell、Thomas E. D'Ambra、E. John Alexander、Sol J. Daum、James H. Ackerman、Monte D. Gruett、Virendra Kumar、Kimberly G. Estep

  DOI：10.1021/jm00016a013

  日期：1995.8

  Aminoalkylindoles (AAIs) are a novel series of cannabinoid receptor ligands. In this report we disclose the structural features of AAIs which are important for binding to this receptor as measured by inhibition of binding of [H-3]Win 55212-2 (5). Functional activity in the mouse vas deferens is also noted and used to distinguish agonists from potential antagonists. The key structural features for potent cannabinoid activity in this series are a bicyclic (naphthyl) substituent at the 3-position, a small (II) substituent at the 2-position, and an aminoethyl (morpholinoethyl) substituent at the 1-position. A 6-bromo analog, Win 54461 (31), has been identified as a potential cannabinoid receptor antagonist. Modeling experiments were done to develop a pharmacophore and also to compare AAI structures with those of classical cannabinoids. The fact that the cannabinoid AAIs arose out of work on a series of cyclooxygenase inhibitors makes sense now that an endogenous cannabinoid ligand has been identified which is a derivative of arachidonic acid. Because of their unique structures and physical properties, AAIs provide useful tools to study the structure and function of the cannabinoid receptor(s).